← Leaderboards
Russell Dahl
Neurodon Llc
$4,804,444
Attributed
$5,883,951
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,883,951 · 7
By mechanism
R44$2,778,247 · 2
R42$1,989,595 · 1
R43$604,761 · 2
R41$511,348 · 2
Top collaborators
- Malek Chouchane3 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPathway InteractionsIn VitroResponsePreventPharmaceutical PreparationsAnimal ModelIn VivoChemistryEndoplasmic ReticulumProteinsCellsPharmacologySmall Business Innovation Research GrantMouse ModelPatient PopulationLead OptimizationLeadPublic HealthApoptosisApoptoticCell DeathCa(2+)-Transporting AtpaseOral
Grant awards (9)
eiF2B Activators to Treat Noise-Induced Hearing Loss$1,554,254
R44 · FY2025 · DC · contact PI
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease$694,864
R44 · FY2024 · AG · contact PI
Development of UPR-Targeted Treatment for Cisplatin-Induced Ototoxicity.$304,762
R43 · FY2024 · DC
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease$529,129
R44 · FY2023 · AG · contact PI
Preclinical evaluation of SERCA2 allosteric activators for pancreatic β-cell protection in diabetes.$286,348
R41 · FY2023 · DK · contact PI
eiF2B Activators to Treat Noise-Induced Hearing Loss$299,999
R43 · FY2022 · DC
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease$1,000,655
R42 · FY2021 · AG · contact PI
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease$988,940
R42 · FY2020 · AG · contact PI
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimerâs disease$225,000
R41 · FY2018 · AG · contact PI